Nissan, Xavier, 1980-....
Xavier Nissan
VIAF ID: 287436704 (Personal)
Permalink: http://viaf.org/viaf/287436704
Preferred Forms
- 100 1 _ ‡a Nissan, Xavier ‡d 1980-...
- 100 1 _ ‡a Nissan, Xavier, ‡d 1980-....
- 100 0 _ ‡a Xavier Nissan
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
Altérations de la voie de signalisation BMP4 responsables de la différenciation accélérée de myoblastes mutés sur le gène LMNA | |
Altered BMP4 pathway leads to accelerated myogenic differentiation of LMNA mutated cells. | |
Biomechanical Strain Exacerbates Inflammation on a Progeria-on-a-Chip Model. | |
Combined mRNA and microRNA profiling reveals that miR-148a and miR-20b control human mesenchymal stem cell phenotype via EPAS1. | |
Concise review: Epidermal grafting: the case for pluripotent stem cells. | |
Development of a cellular model of AMD from patient to study pathophysiology of the disease. | |
Développement d'un modèle cellulaire de la DMLA à partir de cellules de patients pour étudier la physiopathologie de la maladie | |
Drug screening on Hutchinson Gilford progeria pluripotent stem cells reveals aminopyrimidines as new modulators of farnesylation. | |
Epidermis grafting: from adult to embryonic stem cells | |
Étude d'un transcrit alternatif de la dysferline et mise en place d'un traitement pour les dysferlinopathies | |
Functional melanocytes derived from human pluripotent stem cells engraft into pluristratified epidermis. | |
A High Throughput Phenotypic Screening reveals compounds that counteract premature osteogenic differentiation of HGPS iPS-derived mesenchymal stem cells | |
Human embryonic stem-cell derivatives for full reconstruction of the pluristratified epidermis: a preclinical study | |
Identification of thiostrepton as a pharmacological approach to rescue misfolded alpha-sarcoglycan mutant proteins from degradation | |
Improvement of culture conditions of human embryoid bodies using a controlled perfused and dialyzed bioreactor system | |
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin | |
In vitro modeling of hyperpigmentation associated to neurofibromatosis type 1 using melanocytes derived from human embryonic stem cells | |
In vitro pharmacological model of Hutchinson-Gilford progeria syndrome using patient-specific induced pluripotent stem cells. | |
Manipulating cell fate to improve age dependent-tissue regeneration. | |
Manipulation du destin cellulaire pour améliorer la régénération tissulaire au cours du vieillissement | |
[Melanocytes derived from pluripotent stem cells: a new biological resource for pigmentary disorders] | |
MG132-induced progerin clearance is mediated by autophagy activation and splicing regulation. | |
miR-203 modulates epithelial differentiation of human embryonic stem cells towards epidermal stratification | |
miR-9: the sentinel of neurons in progeria | |
Modélisation des néoplasies endocriniennes multiples de type II par les cellules souches pluripotentes induites porteuses de mutations germinales du gène RET | |
Pathological modelling of pigmentation disorders associated with Hutchinson-Gilford Progeria Syndrome (HGPS) revealed an impaired melanogenesis pathway in iPS-derived melanocytes. | |
Study of an alternative transcript of dysferlin and establishment of a treatment for dysferlinopathies. | |
Study of molecular and cellular mechanisms of human pluripotent stem cells differentiation into epidermal lineage. | |
Thérapie cellulaire de la peau : Étude des mécanismes moléculaires impliqués dans les procédés de production de peau humaine reconstituée à partir de dérivés de cellules souches pluripotentes | |
Unique Preservation of Neural Cells in Hutchinson- Gilford Progeria Syndrome Is Due to the Expression of the Neural-Specific miR-9 MicroRNA | |
Using human pluripotent stem cells derived skeletal muscles to address the pathogenesis of recessive limb girdle muscular dystrophy type R2. | |
Utilisation des cellules souches pluripotentes humaines pour modéliser les mécanismes physiopathologiques associés aux dystrophies musculaires des ceintures de type R2 | |
Vers des stratégies pharmacologiques pour des mutations faux-sens dans deux gènes liés aux dystrophies musculaires. | |
Vulnerability of progeroid smooth muscle cells to biomechanical forces is mediated by MMP13 |